The Association Between Gut Microbiota Diversity and Postpartum Depression
2 other identifiers
observational
30
1 country
1
Brief Summary
This study aims to examine whether naturally occurring bacteria in the gastrointestinal tract are associated with mood changes following childbirth, including postpartum depression. Biological samples will be collected before and after delivery to determine whether specific patterns in gut bacterial composition are linked to emotional states. The purpose of the research is to improve understanding of whether such microbial changes can help identify individuals at higher risk for postpartum depression, enabling earlier recognition and intervention.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Nov 2025
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 10, 2025
CompletedFirst Posted
Study publicly available on registry
November 13, 2025
CompletedStudy Start
First participant enrolled
November 17, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2026
CompletedJanuary 15, 2026
November 1, 2025
6 months
November 10, 2025
January 14, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
gut microbiota composition
Compare gut microbiota composition between participants with postpartum depression (defined as Edinburgh Postnatal Depression Scale (EPDS; range 0-30; higher scores indicate more depressive symptoms) ≥13) and without postpartum depression (EPDS \<13).
within 3 days before delivery; within 2 days after delivery
Secondary Outcomes (4)
Association between inflammatory cytokines and postpartum depressive symptom severity
Within 3 days before delivery; within 2 days after delivery
Edinburgh Postnatal Depression Scale (EPDS; range 0-30; higher scores indicate more depressive symptoms)
within 3days before delivery ; within 2 days after delivery; 6 weeks postpartum;
Changes in gut microbiota diversity (alpha and beta)
within 3days before delivery ; within 2 days after delivery
Correlation between relative abundance of selected microbial taxa and maternal depressive symptom severity measured by the Edinburgh Postnatal Depression Scale (EPDS)
within 3days before delivery ; within 2 days after delivery
Study Arms (2)
High-Edinburgh Postnatal Depression Scale cohort
Pregnant participants with antepartum Edinburgh Postnatal Depression Scale (EPDS; range 0-30; higher scores indicate more depressive symptoms) ≥13. Peripheral venous blood (serum) and rectal swab collected ≤3 days pre-delivery and ≤2 days postpartum; optional 6-week follow-up. Observational only-no interventions assigned.
Low-Edinburgh Postnatal Depression Scale cohort
Pregnant individuals with antepartum Edinburgh Postnatal Depression Scale (EPDS; range 0-30; higher scores indicate more depressive symptoms) \<13; same specimen collection and follow-up schedule as the high-EPDS cohort; no interventions assigned.
Eligibility Criteria
Women aged 18 years or older, with gestational age of at least 36 weeks, planning either vaginal or cesarean delivery. Individuals with serious digestive disorders, severe mental health conditions, or recent use of medications such as antibiotics or antidepressants that may affect gut bacteria are excluded.
You may qualify if:
- Age 18 years or older
- Gestational age at least 36 weeks, planned cesarean delivery
- Ability to understand study procedures and provide informed consent
- Voluntary agreement to participate in the study
You may not qualify if:
- Gastrointestinal disorders or recent antibiotic use that significantly alters gut microbiome
- Diagnosis of severe mental illness such as schizophrenia, schizoaffective disorder, bipolar disorder, or major depressive disorder with psychotic features
- Medication use during pregnancy known to influence gut microbiota, including antidepressants, antibiotics, or fish oil
- Refusal to provide rectal swab samples or inability to complete follow-up assessments
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- National Institute on Aging (NIA)collaborator
- Massachusetts General Hospitallead
Study Sites (1)
Meikun Wang
Boston, Massachusetts, 02114, United States
Related Publications (3)
Sun Y, Fan C, Lei D. Association between gut microbiota and postpartum depression: A bidirectional Mendelian randomization study. J Affect Disord. 2024 Oct 1;362:615-622. doi: 10.1016/j.jad.2024.07.057. Epub 2024 Jul 17.
PMID: 39029663BACKGROUNDJin W, Li B, Wang L, Zhu L, Chai S, Hou R. The causal association between gut microbiota and postpartum depression: a two-sample Mendelian randomization study. Front Microbiol. 2024 Sep 2;15:1415237. doi: 10.3389/fmicb.2024.1415237. eCollection 2024.
PMID: 39286351BACKGROUNDZhang Y, Baldyga K, Dong Y, Song W, Villanueva M, Deng H, Mueller A, Houle TT, Marcantonio ER, Xie Z. The association between gut microbiota and postoperative delirium in patients. Transl Psychiatry. 2023 May 9;13(1):156. doi: 10.1038/s41398-023-02450-1.
PMID: 37160886BACKGROUND
Biospecimen
Peripheral venous blood (\~5 mL; processed to serum and plasma) and rectal swab specimens will be collected around the time of delivery (pre-delivery within 3 days and early postpartum within 2 days). Specimens will be coded, stored at -80 °C, and used for laboratory analyses approved by the Institutional Review Board. No direct identifiers accompany specimens. No human whole-genome sequencing is planned.
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor, Harvard Medical School
Study Record Dates
First Submitted
November 10, 2025
First Posted
November 13, 2025
Study Start
November 17, 2025
Primary Completion
May 1, 2026
Study Completion
May 1, 2026
Last Updated
January 15, 2026
Record last verified: 2025-11
Data Sharing
- IPD Sharing
- Will not share
Individual participant data will not be shared. The dataset contains sensitive clinical information from pregnant and postpartum patients at a single institution.